UBTECH ROBOTICS CORP LTD Announces Update on Major Transaction: Acquisition of Major Stake and Board Restructuring
Key Highlights:
- UBTECH ROBOTICS CORP LTD (Stock Code: 9880) has provided an important update regarding its major transaction to acquire significant equity in a Shenzhen-listed target company.
- The company is acquiring a total of 43.01% equity interest in the Target Company, through two components:
- Acquisition of 29.99% equity interest via share transfer agreement
- Partial offer to acquire an additional 13.02% equity interest
- Supplemental agreement signed to amend the Share Transfer Agreement, specifically regarding board composition.
- Board of directors of the Target Company to expand from 7 to 8 members – UBTECH will have rights to nominate 7 out of 8 directors.
- No other material changes to the terms of the Share Transfer Agreement.
Details of the Announcement
UBTECH ROBOTICS CORP LTD (“the Company”) has announced that it has, along with the vendors, entered into a supplemental agreement to the previously disclosed Share Transfer Agreement. The key amendment involves the reconstitution of the board of directors of the Shenzhen-listed Target Company, increasing the board size from seven to eight directors. Crucially, UBTECH will have the right to nominate seven out of these eight directors. This move represents a significant increase in UBTECH’s influence and control over the Target Company.
Implications for Shareholders
- Strategic Control: With the ability to nominate the vast majority of the board, UBTECH is set to gain near-complete influence over the management and strategic direction of the Target Company. This level of control is unusual for a shareholder holding less than a majority stake, and is highly significant.
- Potential Impact on Share Price: The market may view this development positively, as it suggests UBTECH is consolidating its position and may extract greater synergies or value from the Target Company. The ability to drive decision-making could lead to faster execution of strategic initiatives and potentially improved financial performance.
- No Other Material Changes: Aside from the board reconstitution, all other terms of the Share Transfer Agreement remain unchanged. This provides clarity and certainty for investors regarding the remainder of the transaction terms.
Background
The transaction has been in process since at least December 2025, with previous circulars and announcements detailing the acquisition plans and partial offer. The latest update focuses on the governance structure, a crucial aspect for ongoing management and integration.
Board of Directors
As of the date of this announcement, the UBTECH Board comprises:
- Executive Directors: Mr. Zhou Jian, Mr. Liu Ming, Mr. Deng Feng, Dr. Xiong Youjun
- Non-Executive Directors: Mr. Xia Zuoquan, Mr. Zhou Zhifeng, Mr. Lu Kuan
- Independent Non-Executive Directors: Dr. He Jia, Dr. Yao Xin, Dr. Dong Xiuqin, Dr. Xiong Hui
Disclaimer: This article is for informational purposes only, is not investment advice, and does not constitute a recommendation to buy or sell any securities. Investors should conduct their own research or consult their financial advisors before making investment decisions. The information herein is based on the company’s public announcements as of May 27, 2026, and may be subject to further updates or changes.
優必選科技（UBTECH ROBOTICS CORP LTD）重大交易更新：收購主要股權及董事會重組
重點摘要：
- 優必選科技（股份代號：9880）公布關於收購深圳上市目標公司重大股權的最新進展。
- 公司將合共收購目標公司43.01%股權，包括：
- 通過股份轉讓協議收購29.99%股權
- 部分要約收購額外13.02%股權
- 公司與賣方已簽訂補充協議，修改董事會結構。
- 目標公司董事會將由7人增至8人，優必選有權提名其中7名董事。
- 股份轉讓協議其他條款無重大變動。
公告詳情
優必選科技宣布，已與賣方簽訂補充協議，主要修改內容涉及目標公司董事會人數由七人增至八人，並且優必選有權提名其中七名董事。這一變動大大提升優必選對目標公司的控制力和話語權。
對股東的影響
- 戰略控制力： 優必選可提名絕大多數董事，對目標公司管理層及戰略方向擁有接近完全的主導權。對於持股未過半數的股東而言，這種安排極具突破性。
- 對股價的潛在影響： 市場或會正面看待此舉，預期優必選將能更有效整合資源及釋放協同效應，對未來財務表現有正面促進作用。
- 其他條款不變： 除董事會重組外，股份轉讓協議其他條款無重大變動，有助維持交易穩定性與明確性。
背景資料
本次交易自2025年12月起已有多次公告及通函，最新更新重點在於治理結構，對未來業務整合至關重要。
董事會成員
截至公告日，優必選董事會成員包括：
- 執行董事：周劍、劉明、鄧鋒、熊有軍博士
- 非執行董事：夏佐全、周志鋒、盧寬
- 獨立非執行董事：何佳博士、姚欣博士、董秀琴博士、熊輝博士
免責聲明： 本文僅供資訊參考，並不構成任何投資建議或買賣證券的推薦。投資者應自行研究或諮詢財務顧問後再作決定。本文所載資料截至2026年5月27日，未來可能有更新或變更。
